Back to NVO
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Type 2 Diabetes Treated With Insulin
View Full LandscapeDrug Information
Target Indication
Type 2 Diabetes Treated With Insulin
Clinical Trial
NCT04460326Last updated: 10/25/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA1/9/2017
Fiasp
Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
View on EMADrug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
